Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04975256
Title Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mirati Therapeutics Inc.

Advanced Solid Tumor

lung non-small cell carcinoma

colorectal carcinoma


Adagrasib + BI 1701963

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.